Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10018)
All Articles published online
|
Publishing Process of This Article
|
Mar 15, 2022 (publication date) through Dec 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Vij M, Puri Y, Rammohan A, G G, Rajalingam R, Kaliamoorthy I, Rela M. Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review. World J Gastrointest Oncol 2022; 14(3): 607-627 [PMID: 35321284 DOI: 10.4251/wjgo.v14.i3.607] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v14/i3/607.htm |
| Number | Citing Articles |
| 1 |
彬彬 彭. Research Progress on Risk Factors of Cholangiocarcinoma. Advances in Clinical Medicine 2023; 13(03): 4025 doi: 10.12677/ACM.2023.133578
|
| 2 |
Charupong Saengboonmee, Sumalee Obchoei, Kanlayanee Sawanyawisuth, Sopit Wongkham. Revision of potential prognostic markers of cholangiocarcinoma for clinical practice. Expert Review of Anticancer Therapy 2023; 23(5): 517 doi: 10.1080/14737140.2023.2203386
|
| 3 |
Lalita Maria Andersen, Ian Y Goh, Mehan Siriwardhane. High-grade dysplasia of the cystic duct margin: how should this be managed?. BMJ Case Reports 2023; 16(12): e255492 doi: 10.1136/bcr-2023-255492
|
| 4 |
Anastasios Gkountakos, Filippo M. Martelli, Nicola Silvestris, Michele Bevere, Mario De Bellis, Laura Alaimo, Elena Sapuppo, Francesca Masetto, Aldo Mombello, Michele Simbolo, Elena Bariani, Michele Milella, Matteo Fassan, Aldo Scarpa, Claudio Luchini. Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment. Cancers 2023; 15(5): 1454 doi: 10.3390/cancers15051454
|
| 5 |
Aram A. Musaelyan, Ekaterina M. Anokhina, Alina I. Turdubaeva, Natalia V. Mitiushkina, Anastasia N. Ershova, Anna D. Shestakova, Aigul R. Venina, Evgeny N. Imyanitov, Sergey V. Orlov. Response to trametinib, hydroxychloroquine, and bevacizumab in a young woman with NRAS-mutated metastatic intrahepatic cholangiocarcinoma: a case report. Exploration of Targeted Anti-tumor Therapy 2024; 5(3): 780 doi: 10.37349/etat.2024.00246
|
| 6 |
Mathew Vithayathil, Shahid A. Khan. Current epidemiology of cholangiocarcinoma in Western countries. Journal of Hepatology 2022; 77(6): 1690 doi: 10.1016/j.jhep.2022.07.022
|
| 7 |
Yasuni Nakanuma, Yuko Kakuda, Takashi Sugino, Yasunori Sato, Yuki Fukumura. Pathologies of Precursor Lesions of Biliary Tract Carcinoma. Cancers 2022; 14(21): 5358 doi: 10.3390/cancers14215358
|
| 8 |
Sanoop Kumar Sherin Sabu, Vinoth Kumar Ramachandran, U. S. Umashankar, Harriprasad Baskkaran, Swetha Sattanathan, Rajendra Prasad Bollupalle, Yalamanchi Sri Ram Srujan, V. Aravinda Narasimhan, Nair Parvati Ramachandran. Cholangiocarcinoma – A Detailed Review on Indian Literature. Gastroenterology, Hepatology and Endoscopy Practice 2024; 4(4): 151 doi: 10.4103/ghep.ghep_16_24
|
| 9 |
Hrushikesh Wagh, Sankha Bhattacharya. Targeted therapy with polymeric nanoparticles in PBRM1-mutant biliary tract cancers: Harnessing DNA damage repair mechanisms. Critical Reviews in Oncology/Hematology 2024; 204: 104505 doi: 10.1016/j.critrevonc.2024.104505
|
| 10 |
Benjamin J. Van Treeck, Maria C. Olave, Ryan D. Watkins, Haiyan Lu, Roger K. Moreira, Taofic Mounajjed, Michael J. Johnson, Carin Y. Smith, Sumera I. Ilyas, Nguyen H. Tran, Sarah M. Jenkins, Katelyn A. Reed, Rory Smoot, Amit Mahipal, Daniela Allende, Rondell P. Graham. Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma. HPB 2024; 26(7): 938 doi: 10.1016/j.hpb.2024.04.003
|
| 11 |
Faisal Saud Dar, Zaigham Abbas, Irfan Ahmed, Muhammad Atique, Usman Iqbal Aujla, Muhammad Azeemuddin, Zeba Aziz, Abu Bakar Hafeez Bhatti, Tariq Ali Bangash, Amna Subhan Butt, Osama Tariq Butt, Abdul Wahab Dogar, Javed Iqbal Farooqi, Faisal Hanif, Jahanzaib Haider, Siraj Haider, Syed Mujahid Hassan, Adnan Abdul Jabbar, Aman Nawaz Khan, Muhammad Shoaib Khan, Muhammad Yasir Khan, Amer Latif, Nasir Hassan Luck, Ahmad Karim Malik, Kamran Rashid, Sohail Rashid, Mohammad Salih, Abdullah Saeed, Amjad Salamat, Ghias-un-Nabi Tayyab, Aasim Yusuf, Haseeb Haider Zia, Ammara Naveed. National guidelines for the diagnosis and treatment of hilar cholangiocarcinoma. World Journal of Gastroenterology 2024; 30(9): 1018-1042 doi: 10.3748/wjg.v30.i9.1018
|
| 12 |
Yunfang Zhang, Wei Wu, Yan Shi, Yuehong Huang, Ting Dai, Lina Ke, Lizhu Chen, Mingliang Chen, Qin Wang. Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells. International Journal of Molecular Sciences 2024; 25(24): 13440 doi: 10.3390/ijms252413440
|
| 13 |
Ethan Kai Jun Tham, Ryan Yanzhe Lim, Benjamin Koh, Darren Jun Hao Tan, Cheng Han Ng, Michelle Law, Elina Cho, Nicole Shu Ying Tang, Claire Shiying Tan, Benedix Kuan Loo Sim, En Ying Tan, Wen Hui Lim, Mei Chin Lim, Toru Nakamura, Pojsakorn Danpanichkul, Sakkarin Chirapongsathorn, Karn Wijarnpreecha, Hirokazu Takahashi, Asahiro Morishita, Ming-Hua Zheng, Alfred Kow, Mark Muthiah, Jia Hao Law, Daniel Q Huang. Prevalence of Chronic Liver Disease in Cholangiocarcinoma: A Meta-Analysis. Clinical Gastroenterology and Hepatology 2024; doi: 10.1016/j.cgh.2024.09.028
|
| 14 |
Hayat Khizar, Yufei Hu, Weigang Gu, Jin Yang, Hangbin Jin, Xiayin He, Xiaofeng Zhang, Jianfeng Yang. Assessment of safety and adverse events in endoscopic radiofrequency ablation for malignant biliary obstruction. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241294002
|
| 15 |
Benjamin J. Van Treeck, Maria C. Olave, Ryan D. Watkins, Haiyan Lu, Roger K. Moreira, Taofic Mounajjed, Michael J. Johnson, Carin Y. Smith, Sumera I. Ilyas, Nguyen H. Tran, Sarah M. Jenkins, Katelyn A. Reed, Rory Smoot, Amit Mahipal, Daniela Allende, Rondell P. Graham. WITHDRAWN: Neoadjuvant therapy leads to objective response in intrahepatic cholangiocarcinoma. HPB 2024; doi: 10.1016/j.hpb.2024.04.011
|
| 16 |
Maria Qurashi, Mathew Vithayathil, Shahid A. Khan. Epidemiology of cholangiocarcinoma. European Journal of Surgical Oncology 2023; : 107064 doi: 10.1016/j.ejso.2023.107064
|
| 17 |
Matt Evans, Timothy Kendall. Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices. Expert Review of Molecular Diagnostics 2024; 24(5): 393 doi: 10.1080/14737159.2024.2353696
|
| 18 |
Carina Teixeira, Bárbara Viamonte, Luís Graça, Hugo Pinto Marques, Inês Rego, Maria João Ribeiro. Liver Transplant After Neoadjuvant Treatment for Long-Term Survivors With Intrahepatic Cholangiocarcinoma: Does It Have a Role?. Cureus 2024; doi: 10.7759/cureus.75935
|
| 19 |
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N. Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean Pavlick, Anil Korkut, Jeffrey S. Ross, Milind Javle. Comprehensive Immunogenomic Profiling of IDH1-/2-Altered Cholangiocarcinoma. JCO Precision Oncology 2024; (8) doi: 10.1200/PO.23.00544
|